GLMD vs. SIVR

Last updated Apr 1, 2026

Compare and contrast key facts about Galmed Pharmaceuticals Ltd. (GLMD) and Aberdeen Standard Physical Silver Shares ETF (SIVR).

SIVR is a passively managed fund by Aberdeen that tracks the performance of the LBMA Silver Price ($/ozt). It was launched on Jul 24, 2009.

Performance

GLMD vs. SIVR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Galmed Pharmaceuticals Ltd. (GLMD) and Aberdeen Standard Physical Silver Shares ETF (SIVR). The values are adjusted to include any dividend payments, if applicable.

GLMD vs. SIVR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
GLMD Galmed Pharmaceuticals Ltd.	-34.71%	-76.47%	-41.58%	-93.93%	-72.53%	-41.48%	-46.19%	-15.37%	-25.36%	160.68%
SIVR Aberdeen Standard Physical Silver Shares ETF	5.87%	145.34%	21.08%	-0.91%	2.59%	-12.33%	47.52%	15.17%	-8.96%	5.97%

Returns By Period

In the year-to-date period, GLMD achieves a -34.71% return, which is significantly lower than SIVR's 5.87% return. Over the past 10 years, GLMD has underperformed SIVR with an annualized return of -52.88%, while SIVR has yielded a comparatively higher 17.11% annualized return.

GLMD

• 1D: 3.17%
• 1M: -19.87%
• YTD: -34.71%
• 6M: -64.49%
• 1Y: -65.97%
• 3Y*: -81.45%
• 5Y*: -76.03%
• 10Y*: -52.88%

SIVR

• 1D: 7.36%
• 1M: -19.77%
• YTD: 5.87%
• 6M: 60.99%
• 1Y: 120.27%
• 3Y*: 45.79%
• 5Y*: 24.36%
• 10Y*: 17.11%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

GLMD vs. SIVR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GLMD

GLMD Risk / Return Rank: 10
GLMD Sharpe Ratio Rank: 9
GLMD Sortino Ratio Rank: 9
GLMD Omega Ratio Rank: 11
GLMD Calmar Ratio Rank: 9
GLMD Martin Ratio Rank: 10

SIVR

SIVR Risk / Return Rank: 89
SIVR Sharpe Ratio Rank: 93
SIVR Sortino Ratio Rank: 86
SIVR Omega Ratio Rank: 92
SIVR Calmar Ratio Rank: 90
SIVR Martin Ratio Rank: 83

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GLMD vs. SIVR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Galmed Pharmaceuticals Ltd. (GLMD) and Aberdeen Standard Physical Silver Shares ETF (SIVR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	GLMD	SIVR	Difference
Sharpe ratio Return per unit of total volatility	-0.78	2.12	-2.90
Sortino ratio Return per unit of downside risk	-1.14	2.21	-3.34
Omega ratio Gain probability vs. loss probability	0.87	1.39	-0.53
Calmar ratio Return relative to maximum drawdown	-0.87	2.84	-3.71
Martin ratio Return relative to average drawdown	-1.47	8.85	-10.32
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

GLMD vs. SIVR - Sharpe Ratio Comparison

The current GLMD Sharpe Ratio is -0.78, which is lower than the SIVR Sharpe Ratio of 2.12. The chart below compares the historical Sharpe Ratios of GLMD and SIVR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	GLMD	SIVR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.78	2.12	-2.90
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.46	0.69	-1.15
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.38	0.55	-0.93
Sharpe Ratio (All Time) Calculated using the full available price history	-0.39	0.33	-0.72

Correlation

The correlation between GLMD and SIVR is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

GLMD vs. SIVR - Dividend Comparison

Neither GLMD nor SIVR has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

GLMD vs. SIVR - Drawdown Comparison

The maximum GLMD drawdown since its inception was -99.99%, which is greater than SIVR's maximum drawdown of -75.85%. Use the drawdown chart below to compare losses from any high point for GLMD and SIVR.

Drawdown Indicators

	GLMD	SIVR	Difference
Max Drawdown Largest peak-to-trough decline	-99.99%	-75.85%	-24.14%
Max Drawdown (1Y) Largest decline over 1 year	-79.62%	-42.42%	-37.20%
Max Drawdown (5Y) Largest decline over 5 years	-99.93%	-42.42%	-57.51%
Max Drawdown (10Y) Largest decline over 10 years	-99.99%	-42.42%	-57.57%
Current Drawdown Current decline from peak	-99.98%	-35.41%	-64.57%
Average Drawdown Average peak-to-trough decline	-73.98%	-48.00%	-25.98%
Ulcer Index Depth and duration of drawdowns from previous peaks	46.95%	13.61%	+33.34%

Volatility

GLMD vs. SIVR - Volatility Comparison

Galmed Pharmaceuticals Ltd. (GLMD) has a higher volatility of 22.33% compared to Aberdeen Standard Physical Silver Shares ETF (SIVR) at 18.93%. This indicates that GLMD's price experiences larger fluctuations and is considered to be riskier than SIVR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GLMD	SIVR	Difference
Volatility (1M) Calculated over the trailing 1-month period	22.33%	18.93%	+3.40%
Volatility (6M) Calculated over the trailing 6-month period	58.23%	57.26%	+0.97%
Volatility (1Y) Calculated over the trailing 1-year period	85.06%	57.02%	+28.04%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	165.53%	35.31%	+130.22%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	137.94%	31.39%	+106.55%